Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Cyclerion Therapeutics (CYCN)

Cyclerion Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYCN
DateTimeSourceHeadlineSymbolCompany
07/05/202421:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYCNCyclerion Therapeutics Inc
26/01/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYCNCyclerion Therapeutics Inc
11/12/202322:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CYCNCyclerion Therapeutics Inc
07/12/202321:05Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CYCNCyclerion Therapeutics Inc
04/12/202322:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
04/12/202321:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CYCNCyclerion Therapeutics Inc
04/12/202313:00GlobeNewswire Inc.Cyclerion Appoints Regina Graul, Ph.D., as PresidentNASDAQ:CYCNCyclerion Therapeutics Inc
01/12/202313:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
30/11/202323:16GlobeNewswire Inc.Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge InnovatorNASDAQ:CYCNCyclerion Therapeutics Inc
24/11/202318:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
13/11/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYCNCyclerion Therapeutics Inc
23/10/202321:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
31/07/202312:00GlobeNewswire Inc.Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion AssetsNASDAQ:CYCNCyclerion Therapeutics Inc
28/07/202321:48Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYCNCyclerion Therapeutics Inc
19/07/202322:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
12/07/202321:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYCNCyclerion Therapeutics Inc
20/06/202321:56Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:CYCNCyclerion Therapeutics Inc
09/06/202322:24Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:CYCNCyclerion Therapeutics Inc
01/06/202321:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCNCyclerion Therapeutics Inc
01/06/202321:00GlobeNewswire Inc.Cyclerion Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:CYCNCyclerion Therapeutics Inc
25/05/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCNCyclerion Therapeutics Inc
23/05/202321:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CYCNCyclerion Therapeutics Inc
15/05/202322:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCNCyclerion Therapeutics Inc
15/05/202318:00GlobeNewswire Inc.Cyclerion Announces Reverse Stock SplitNASDAQ:CYCNCyclerion Therapeutics Inc
12/05/202313:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CYCNCyclerion Therapeutics Inc
12/05/202311:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYCNCyclerion Therapeutics Inc
11/05/202323:00GlobeNewswire Inc.Cyclerion Announces Definitive Agreement for Zagociguat and CY3018NASDAQ:CYCNCyclerion Therapeutics Inc
11/05/202323:00GlobeNewswire Inc.Cyclerion Announces Corporate Updates and Q1 2023 Financial ResultsNASDAQ:CYCNCyclerion Therapeutics Inc
03/04/202314:54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCNCyclerion Therapeutics Inc
03/04/202312:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CYCNCyclerion Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CYCN